These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24258988)

  • 21. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
    Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
    Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Costimulatory molecule expression on human uveal melanoma cells: functional analysis of CD40 and B7-H1.
    Ma J; Usui Y; Kezuka T; Okunuki Y; Zhang L; An X; Mizota A; Goto H
    Exp Eye Res; 2012 Mar; 96(1):98-106. PubMed ID: 22200489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the co-stimulatory molecule CD40 on melanoma cells.
    Thomas WD; Smith MJ; Si Z; Hersey P
    Int J Cancer; 1996 Dec; 68(6):795-801. PubMed ID: 8980186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-G expression in human melanoma cells: protection from NK cytolysis.
    Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
    J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negative roles of B7-H3 and B7-H4 in the microenvironment of cervical cancer.
    Han S; Wang Y; Shi X; Zong L; Liu L; Zhang J; Qian Q; Jin J; Ma Y; Cui B; Yang X; Kong B; Zhang Y
    Exp Cell Res; 2018 Oct; 371(1):222-230. PubMed ID: 30099052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7-H4 expression by nonhematopoietic cells in the tumor microenvironment promotes antitumor immunity.
    Rahbar R; Lin A; Ghazarian M; Yau HL; Paramathas S; Lang PA; Schildknecht A; Elford AR; Garcia-Batres C; Martin B; Berman HK; Leong WL; McCready DR; Reedijk M; Done SJ; Miller N; Youngson B; Suh WK; Mak TW; Ohashi PS
    Cancer Immunol Res; 2015 Feb; 3(2):184-95. PubMed ID: 25527357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The expression, function, and clinical relevance of B7 family members in cancer.
    Seliger B; Quandt D
    Cancer Immunol Immunother; 2012 Aug; 61(8):1327-41. PubMed ID: 22695874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-small cell lung cancer induces an immunosuppressive phenotype of dendritic cells in tumor microenvironment by upregulating B7-H3.
    Schneider T; Hoffmann H; Dienemann H; Schnabel PA; Enk AH; Ring S; Mahnke K
    J Thorac Oncol; 2011 Jul; 6(7):1162-8. PubMed ID: 21597388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
    MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
    J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of increased B7 protein expression by infiltrating immune cells with progression of gastric carcinogenesis.
    Guo L; Liu Z; Zhang Y; Quan Q; Huang L; Xu Y; Cao L; Zhang X
    Medicine (Baltimore); 2019 Feb; 98(8):e14663. PubMed ID: 30813210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases.
    van Duinen SG; Ruitter DJ; Ferrone S
    J Pathol; 1986 Aug; 149(4):339-48. PubMed ID: 3531448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of HLA antigen expression in benign and malignant melanocytic lesions reveals that upregulation of HLA-G expression correlates with malignant transformation, high inflammatory infiltration and HLA-A1 genotype.
    Ibrahim EC; Aractingi S; Allory Y; Borrini F; Dupuy A; Duvillard P; Carosella ED; Avril MF; Paul P
    Int J Cancer; 2004 Jan; 108(2):243-50. PubMed ID: 14639610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigens associated with tumor progression in melanocytic neoplasia.
    Elder DE; Herlyn M
    Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
    [No Abstract]   [Full Text] [Related]  

  • 34. Bispecific anti-CD3 x anti-B7-H3 antibody mediates T cell cytotoxic ability to human melanoma in vitro and in vivo.
    Ma J; Shang T; Ma P; Sun X; Zhao J; Sun X; Zhang M
    Invest New Drugs; 2019 Oct; 37(5):1036-1043. PubMed ID: 30706335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma.
    Altomonte M; Visintin A; Tecce R; Leonardi A; Calabro L; Fonsatti E; Pucillo C; Maio M
    J Cell Physiol; 2004 Aug; 200(2):272-6. PubMed ID: 15174097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overall survival and PD-L1 expression in metastasized malignant melanoma.
    Gadiot J; Hooijkaas AI; Kaiser AD; van Tinteren H; van Boven H; Blank C
    Cancer; 2011 May; 117(10):2192-201. PubMed ID: 21523733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Switch of HLA-G alternative splicing in a melanoma cell line causes loss of HLA-G1 expression and sensitivity to NK lysis.
    Rouas-Freiss N; Bruel S; Menier C; Marcou C; Moreau P; Carosella ED
    Int J Cancer; 2005 Oct; 117(1):114-22. PubMed ID: 15880415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recognition of gp43 tumor-associated antigen peptide by both HLA-A2 restricted CTL lines and antibodies from melanoma patients.
    Takahashi T; Irie RF; Morton DL; Hoon DS
    Cell Immunol; 1997 Jun; 178(2):162-71. PubMed ID: 9225007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T cell activation by antigens on human melanoma cells--co-stimulation by B7-1 is neither sufficient nor necessary to stimulate IL-2 secretion by melanoma-specific T cell clones in vitro.
    Viret C; Gervois N; Guilloux Y; Le Dréan E; Diez E; Jotereau F
    Int Immunol; 1995 Oct; 7(10):1535-43. PubMed ID: 8562498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.